Penn Heart and Vascular

Carotid Treatments at the Vascular Surgery and Endovascular Therapy Program

Quality & Outcomes: Carotid Treatments for High–Risk Stroke Patients

Penn vascular surgeons currently treat more than 150 patients each year, with perioperative stroke and mortality rates below 1 percent.

For patients at high risk for a stroke from carotid plaque, treatments include traditional carotid endarterectomy as well as carotid stenting with distal protection.

Stenosis as a result of atherosclerosis of the carotid system accounts for 25 percent of cerebrovascular accidents in the U.S. Penn is a national leader in the treatment of carotid stenosis and the development of new therapies for the condition.

The division of vascular surgery and endovascular therapy participated in early FDA-approved clinical trials for carotid stenting, leading to FDA approval of the first carotid stent with distal protection platform in the country.

A long-standing collaboration with Penn stroke neurologists has optimized care of patients with symptomatic and asymtomatic carotid disease.

Penn Heart & Vascular Clinical Activity Reports

See Interactive Report or Download PDF Version

Upcoming Events